Next Article in Journal
Fighting Microbial Infections from Escherichia coli O157:H7: The Combined Use of Three Essential Oils of the Cymbopogon Genus and a Derivative of Esculentin-1a Peptide
Next Article in Special Issue
First Data on WGS-Based Typing and Antimicrobial Resistance of Human Salmonella Enteritidis Isolates in Greece
Previous Article in Journal
Anovaginal Colonization by Group B Streptococcus and Streptococcus anginosus among Pregnant Women in Brazil and Its Association with Clinical Features
Previous Article in Special Issue
Antimicrobial Resistance in Escherichia coli Isolated from Healthy Dogs and Cats in South Korea, 2020–2022
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Using a Stakeholder Analysis to Implement the Belgian One Health National Report for Antimicrobial Use and Resistance

1
Coordination of Veterinary Activities Service, Infectious Diseases in Animals Department, Sciensano, 1050 Brussels, Belgium
2
Healthcare-Associated Infections and Antimicrobial Resistance Service, Epidemiology and Public Health Department, Sciensano, 1050 Brussels, Belgium
3
Strategy and External Positioning, Sciensano, 1050 Brussels, Belgium
4
Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
5
Animal Production, Ichthyology, Ecology and Protection of the Environment Department, Health Sciences School, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
Antibiotics 2024, 13(1), 84; https://doi.org/10.3390/antibiotics13010084
Submission received: 30 November 2023 / Revised: 4 January 2024 / Accepted: 6 January 2024 / Published: 16 January 2024

Abstract

(1) Background. Antimicrobial resistance (AMR) poses a substantial global health threat with profound economic implications. Acknowledging the imperative for a One Health (OH) strategy to combat this menace, Belgium introduced an annual national OH report, known as the “BELMAP report,” encompassing antimicrobial use (AMU) and AMR, with the first edition completed in 2021. The integration of innovations for the healthcare system demands a meticulously planned process. (2) Methods. We introduced a three-step stakeholder analysis (SA) as a prospective framework for navigating this new report process, fostering complementary collaboration, pinpointing obstacles, suggesting approaches to overcome them, and facilitating national policy development. The SA unfolds in three steps: stakeholders identify and list their relevant activities, assess their positions regarding the BELMAP report, and complete “actor mapping” of national AMR and AMU stakeholders. (3) Results. Stakeholder identification reveals a fragmented landscape of AMR and AMU activities across Belgium. Assessment of stakeholder positions uncovers diverse expectations, collaborative challenges, and resource considerations. “Actor mapping” identifies key stakeholders, emphasizing the importance of high-interest and high-power actors. (4) Conclusions. This SA approach not only provides insights into the present stakeholder landscape in Belgium, it can also serve as a blueprint for other countries in the process of developing OH reports.
Keywords: stakeholder analysis; BELMAP; antimicrobial resistance; antimicrobial surveillance stakeholder analysis; BELMAP; antimicrobial resistance; antimicrobial surveillance

Share and Cite

MDPI and ACS Style

Cargnel, M.; Kelly, M.; Imberechts, H.; Catry, B.; Filippitzi, M.-E. Using a Stakeholder Analysis to Implement the Belgian One Health National Report for Antimicrobial Use and Resistance. Antibiotics 2024, 13, 84. https://doi.org/10.3390/antibiotics13010084

AMA Style

Cargnel M, Kelly M, Imberechts H, Catry B, Filippitzi M-E. Using a Stakeholder Analysis to Implement the Belgian One Health National Report for Antimicrobial Use and Resistance. Antibiotics. 2024; 13(1):84. https://doi.org/10.3390/antibiotics13010084

Chicago/Turabian Style

Cargnel, Mickaël, Moira Kelly, Hein Imberechts, Boudewijn Catry, and Maria-Eleni Filippitzi. 2024. "Using a Stakeholder Analysis to Implement the Belgian One Health National Report for Antimicrobial Use and Resistance" Antibiotics 13, no. 1: 84. https://doi.org/10.3390/antibiotics13010084

APA Style

Cargnel, M., Kelly, M., Imberechts, H., Catry, B., & Filippitzi, M.-E. (2024). Using a Stakeholder Analysis to Implement the Belgian One Health National Report for Antimicrobial Use and Resistance. Antibiotics, 13(1), 84. https://doi.org/10.3390/antibiotics13010084

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop